John A. Latham, Chief Scientific Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 24,999 shares at $17.99 ($450K) on 2018-09-04, disclosed to the SEC on 2018-09-06.
Open-market sale of $450k ALDR by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALDR | SELL | 2018-07-03 | $387K | — | Filing → |
| ALDR | SELL | 2018-06-05 | $446K | — | Filing → |
| ALDR | SELL | 2016-12-05 | $83K | — | Filing → |